Patenting human embryonic stem cells in peril: the decision of the Enlarged Board of Appeal in G 2/06

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The Enlarged Board of Appeal has recently decided one of the most sensitive cases it has ever had on its hands, but probably not the last. The referral in the G 2/06 case related to the patentability of human embryonic stem cells (hESC). The main question was whether inventions pertaining to the hESC should be excluded from patentability in the basis of being contrary to order public and morality.
Original languageEnglish
JournalBio-Science Law Review
Volume10
Issue number1
Pages (from-to)13-24
Number of pages12
ISSN1365-8867
Publication statusPublished - 2009

Cite this